Cidara Therapeutics Corp (CDTX): Earnings per share for the last twelve months

Corporate company logo of Cidara Corp (CDTX)

Cidara Therapeutics (CDTX) maintains competent management that ensures R&D transparency and the effective commercialization of drugs. The TTM earnings per share trend reported by the GURU.Markets portal confirms this, where the -11.84 metric determines the parameter status. The monopoly pricing power of its innovations is balanced by a critical dependence on external tranches and a deficit of working capital, necessitating strict resource control.

Cidara (CDTX) - Net earnings per share (EPS TTM) from 07/04/2022 to 01/17/2026

CDTX (Cidara Corp): analytical breakdowns and indicator data

Fundamental company analysis:Cidara Therapeutics Corp (CDTX)
Manufactured products of Cidara Therapeutics Corp

This indicator captures the real return on issued capital, stripping the financial result of market volatility and the impact of share volume. Investors analyze the trailing 12-month net income per share with a value of -11.84 to assess management efficiency, which for Cidara Therapeutics (CDTX) depends directly on the stability of international biocomponent supplies to eliminate resource bottlenecks in laboratories.

Direct competitors

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Novavax Inc NVAX|CureVac Corp (CVAC) - Earnings per share for the last twelve months|Valneva SE - Earnings per share for the trailing year|Earnings per share for the last twelve months vir.bio|Net earnings per share (EPS TTM) siga.com|Net earnings per share (EPS TTM) EBS|Net earnings per share for the last four quarters Atea Pharmaceuticals, Inc.|Net earnings per share (EPS TTM) IVVD (invivyd.com)|Enanta Pharmaceuticals, Inc (ENTA) - Net earnings per one share for the last twelve months|INO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters